Sharecast News
27 May, 2022 16:11

Director dealings: Creo Medical board members add to holdings

dl creo medical group aim surgical endoscopy medical devices logo
Creo MedicalSharecast graphic / Josh White

Creo Medical Group had several entries on the list of director buys on Friday, after it disclosed three share purchases made by two of its board members.

The AIM-traded firm said non-executive chairman Charles Spicer purchased 15,435 shares at a price of 97.18p each, spending a total of £14,999.73.

Following the transaction, Spicer's total direct interest in the company held via his self-invested personal pension was now 143,411 shares, representing 0.08% of its issued capital.

Chief financial officer Richard Rees, meanwhile, purchased a total of 70,000 shares at a price of 96.75p apiece.

It said Rees purchased 21,400 of those into his self-invested pension plan, for a total of £20,704.50, while the remaining 48,600 were purchased for a total value of £47,020.50.

Creo said Rees' total direct interest in the company was now 73,615 shares, representing 0.04% of its issued capital.

Reporting by Josh White at Sharecast.com.

Top Director Buys

I3 Energy (I3E)
Director name: Festival,John
Amount purchased: 354,500 @ $0.44
Value: $91,230.90

Surface Transforms (SCE)
Director name: Cleminson,Ian
Amount purchased: 102,053 @ 49.00p
Value: £50,005.97

Bakkavor Group (BAKK)
Director name: Lodge ,Jane Ann
Amount purchased: 50,000 @ 100.00p
Value: £50,000.00

Smithson Investment Trust (SSON)
Director name: Bartlett,Diana Dyer
Amount purchased: 3,886 @ 1,280.00p
Value: £49,740.80

Creo Medical Group (CREO)
Director name: Rees,Richard John
Amount purchased: 48,600 @ 96.75p
Value: £47,020.50

Creo Medical Group (CREO)
Director name: Rees,Richard John
Amount purchased: 21,400 @ 96.75p
Value: £20,704.50

Creo Medical Group (CREO)
Director name: Spicer,Charles
Amount purchased: 15,435 @ 97.18p
Value: £14,999.73


News Source: © 2022 Web Financial Group (UK) Limited. All rights reserved and terms of use apply.

Important Legal Notice about News Sources: Pilling and Co Stockbrokers Ltd. is not responsible for the content or accuracy of third party news and we may not share the views of the author or publisher. We provide third party news for your convenience and information only and make no representation or endorsement whatsoever and hereby exclude all liability for any loss or damage that may be incurred by you as a result of your access or use. Please note that third party content may be subject to terms and conditions imposed by the third party owner of that content.

The value of investments can fall and you may get back less than you invested.

 

Important Legal Notice about News Sources

Pilling and Co Stockbrokers Ltd. is not responsible for the content or accuracy of third party news articles and we may not share the views of the author or publisher.

We provide third party news for your convenience and information only and make no representation or endorsement whatsoever and hereby exclude all liability for any loss or damage that may be incurred by you as a result of your access or use. Please note that third party content may be subject to terms and conditions imposed by the third party owner of that content.

The value of investments can fall and you may get back less than you invested.